Prevention of adverse reactions involves a multi-faceted approach. This includes thorough preclinical testing, careful clinical trial design, and robust pharmacovigilance. Educating healthcare providers and patients about potential risks and the importance of adherence to prescribed dosages is also essential in minimizing risks.
